by CheckRare Staff | Feb 19, 2024
Bernd Kasper, MD, PhD, Mannheim Cancer Center at University of Heidelberg in Germany, and Principal Investigator of the DeFi trial, discusses desmoid tumors and the approval of Ogsiveo (nirogacestat). A desmoid tumor is a benign, locally invasive...
by CheckRare Staff | Feb 17, 2024
Nicole Miller, PhD, Vice President of Molecular Diagnostics at Ultragenyx Pharmaceutics, explains the importance of improving newborn screening and the limitations of current processes. The Recommended Uniform Screening Panel (RUSP) is a list of...
by CheckRare Staff | Feb 16, 2024
« Prev1 / 1Next »Subtypes of CTCL: Mycosis Fungoides and Sézary Syndrome (Full Interview)CTCL: Mycosis Fungoides and Sézary Syndrome Overview (Chapter 1)Diagnosis of Mycosis Fungoides and Sézary Syndrome (Chapter 2)Importance of Accurate Staging When...
by CheckRare Staff | Feb 16, 2024
Wei Ying Jen, MD, of the Department of Leukemia at the University of Texas MD Anderson Cancer Center, discusses Philadelphia chromosome-positive acute lymphoblastic leukemia and treatment options. Philadelphia chromosome (Ph)-positive acute lymphoblastic...
by CheckRare Staff | Feb 13, 2024
Jörg Schüttrumpf, MD, Chief Scientific Innovation Officer at Grifols, discusses the Phase 1/2 study evaluating a breakthrough treatment option for alpha1-antitrypsin deficiency. Alpha-1 antitrypsin deficiency (AATD) is an inherited disease caused by...
